Phibro Animal Health Corp
PAHC37.640USD
+1.060+2.90%
Cierre 10/14, 16:00（ET）Cotizaciones retrasadas 15 min
1.53BCap. mercado
31.61P/E TTM
Más Datos de Phibro Animal Health Corp Compañía
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Información de Phibro Animal Health Corp
Símbolo de cotizaciónPAHC
Nombre de la empresaPhibro Animal Health Corp
Fecha de salida a bolsaApr 11, 2014
Director ejecutivoMr. Jack C. Bendheim
Número de empleados1940
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 11
DirecciónGlenpointe Centre East, 3Rd Floor
CiudadTEANECK
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal07666
Teléfono12013297300
Sitio Webhttps://www.pahc.com/
Símbolo de cotizaciónPAHC
Fecha de salida a bolsaApr 11, 2014
Director ejecutivoMr. Jack C. Bendheim
Ejecutivos de Phibro Animal Health Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+4.14%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-13.90%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-14.73%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Judith A. Weinstein
Ms. Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Ms. Joyce J. Lee
Ms. Joyce J. Lee
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+4.14%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-13.90%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-14.73%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
MFAs and Other
646.35M
49.86%
Nutritional specialties
179.29M
13.83%
Vaccines
137.15M
10.58%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
739.92M
57.08%
Latin America and Canada
298.65M
23.04%
Europe & Middle East & Africa
160.23M
12.36%
Asia Pacific
97.42M
7.52%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
MFAs and Other
646.35M
49.86%
Nutritional specialties
179.29M
13.83%
Vaccines
137.15M
10.58%
Estadísticas de accionistas
Actualizado: jue., 2 de oct
Actualizado: jue., 2 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.45%
The Vanguard Group, Inc.
7.58%
State Street Investment Management (US)
4.46%
Acadian Asset Management LLC
3.56%
ExodusPoint Capital Management, LP
3.34%
Otro
66.61%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.45%
The Vanguard Group, Inc.
7.58%
State Street Investment Management (US)
4.46%
Acadian Asset Management LLC
3.56%
ExodusPoint Capital Management, LP
3.34%
Otro
66.61%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.94%
Investment Advisor/Hedge Fund
29.11%
Hedge Fund
15.11%
Research Firm
2.79%
Pension Fund
1.76%
Individual Investor
0.52%
Bank and Trust
0.39%
Corporation
0.29%
Sovereign Wealth Fund
0.05%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
381
21.46M
105.37%
-2.37M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
2023Q2
341
20.61M
101.32%
-2.12M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
2.94M
14.45%
-161.95K
-5.22%
Jun 30, 2025
The Vanguard Group, Inc.
1.54M
7.58%
+26.73K
+1.76%
Jun 30, 2025
State Street Investment Management (US)
909.33K
4.46%
-10.87K
-1.18%
Jun 30, 2025
Acadian Asset Management LLC
724.44K
3.56%
-58.50K
-7.47%
Jun 30, 2025
ExodusPoint Capital Management, LP
680.38K
3.34%
+680.38K
--
Jun 30, 2025
Renaissance Technologies LLC
610.80K
3%
-94.50K
-13.40%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
557.24K
2.74%
-86.67K
-13.46%
Jun 30, 2025
Geode Capital Management, L.L.C.
554.93K
2.72%
+7.84K
+1.43%
Jun 30, 2025
Castleknight Management LP
531.35K
2.61%
+113.60K
+27.19%
Jun 30, 2025
Nuveen LLC
458.57K
2.25%
-23.24K
-4.82%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
AAM Sawgrass US Small Cap Quality Growth ETF
2.22%
Brandes US Small-Mid Cap Value ETF
1.44%
SPDR S&P Pharmaceuticals ETF
1.04%
Invesco S&P SmallCap 600 Pure Growth ETF
0.94%
Lattice Hartford Multifactor Small Cap ETF
0.87%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.6%
Invesco S&P SmallCap Health Care ETF
0.51%
Royce Quant Small-Cap Quality Value ETF
0.37%
Zacks Small/Mid Cap ETF
0.35%
Ver más
AAM Sawgrass US Small Cap Quality Growth ETF
Proporción2.22%
Brandes US Small-Mid Cap Value ETF
Proporción1.44%
SPDR S&P Pharmaceuticals ETF
Proporción1.04%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción0.94%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.87%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporción0.76%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.6%
Invesco S&P SmallCap Health Care ETF
Proporción0.51%
Royce Quant Small-Cap Quality Value ETF
Proporción0.37%
Zacks Small/Mid Cap ETF
Proporción0.35%
Dividendos
Un total de
97.20M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
May 01, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 28, 2023 going ex on Jun 06, 2023
Jun 07, 2023
Jun 28, 2023
Jun 06, 2023
Feb 06, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 22, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 22, 2023
Feb 28, 2023
Nov 07, 2022
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 21, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 21, 2022
Nov 29, 2022
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
